𝔖 Bobbio Scriptorium

✦ LIBER ✦

Local Perivascular Delivery of Basic Fibroblast Growth Factor in Patients Undergoing Coronary Bypass Surgery : Results of a Phase I Randomized, Double-Blind, Placebo-Controlled Trial

✍ Scribed by Laham, R. J.; Sellke, F. W.; Edelman, E. R.; Pearlman, J. D.; Ware, J. A.; Brown, D. L.; Gold, J. P.; Simons, M.

Book ID: 127282042
Publisher: Lippincott Williams and Wilkins
Year: 1999
Tongue: English
Weight: 473 KB
Volume: 100
Category: Article
ISSN: 0009-7322
DOI: 10.1161/01.cir.100.18.1865

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Changes in fibroblast growth factor 23 l

Changes in fibroblast growth factor 23 levels in normophosphatemic patients with chronic kidney disease stage 3 treated with lanthanum carbonate: results of the PREFECT study, a phase 2a, double blind, randomized, placebo-controlled trial

✍ Ureña-Torres, Pablo; Prié, Dominique; Keddad, Karim; Preston, Peter; Wilde, Paul 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 220 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled, multicenter study to evaluate the cardioprotective effects of MC-1 in patients undergoing high-risk coronary artery bypass graft surgery: MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery Trial (MEND-CABG) II—study design and rationale

✍ Rajendra H. Mehta; John H. Alexander; Robert Emery; Stephen J. Ellis; Vic Hassel 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 209 KB